Inventor · disambiguated record
Bin Yang
Also filed as: YANG BIN · YANG BIN S
38 granted patents·23 pending applications·290 citations·filing 2002–2025
97Inventor score
Files withKYMERA THERAPEUTICS INC15ASTRAZENECA AB14DIMARCHI RICHARD D5UNIV INDIANA RES & TECH CORP4CALIFORNIA INST OF TECHN3
Top patents by PatentIndex Score
61 records- 0199US9778155B2Methods for phenotyping of intact whole tissuesCALIFORNIA INST OF TECHN·Filed 2015·Granted Oct 3, 2017·56 cites·22 claims
- 0298US11746120B2Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·12 cites·30 claims
- 0398US11485750B1STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Nov 1, 2022·7 cites·20 claims
- 0497US12077555B2STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 3, 2024·3 cites·14 claims
- 0596US6653443B2Multimerization of HIV-1 Vif protein as a therapeutic targetUNIV JEFFERSON·Filed 2002·Granted Nov 25, 2003·69 cites·1 claims
- 0695US8729017B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2012·Granted May 20, 2014·29 cites·23 claims
- 0794US7875444B2Lignin blockers and uses thereofDARTMOUTH COLLEGE·Filed 2005·Granted Jan 25, 2011·22 cites·21 claims
- 0893US9778154B2Methods for phenotyping of intact whole tissuesCALIFORNIA INST OF TECHN·Filed 2014·Granted Oct 3, 2017·10 cites·19 claims
- 0991US8981047B2Glucagon antagonistsDIMARCHI RICHARD D·Filed 2008·Granted Mar 17, 2015·15 cites·23 claims
- 1091US7604967B2Lignin-blocking treatment of biomass and uses thereofDARTMOUTH COLLEGE·Filed 2003·Granted Oct 20, 2009·20 cites·20 claims
- 1186US8980830B2Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activityDIMARCHI RICHARD D·Filed 2008·Granted Mar 17, 2015·15 cites·22 claims
- 1285US2025059221A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1385US2024383895A1Chemical compoundsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1481US10131663B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Nov 20, 2018·2 cites·6 claims
- 1581US8580541B2Lignin blockers and uses thereofYANG BIN·Filed 2010·Granted Nov 12, 2013·3 cites·20 claims
- 1678US10131889B1Candida antarctica lipase B mutant, and methods for making and using the sameLIU LIMING·Filed 2017·Granted Nov 20, 2018·2 cites·9 claims
- 1778US9783592B2Glucagon superfamily peptides exhibiting nuclear hormone receptor activityUNIV INDIANA RES & TECH CORP·Filed 2015·Granted Oct 10, 2017·2 cites·21 claims
- 1878US7498138B2Multimerization of HIV-1 Vif protein as a therapeutic targetUNIV JEFFERSON·Filed 2007·Granted Mar 3, 2009·2 cites·17 claims
- 1977US9309301B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2012·Granted Apr 12, 2016·2 cites·24 claims
- 2076US8461170B2Chemical compoundsAQUILA BRIAN·Filed 2011·Granted Jun 11, 2013·7 cites·2 claims
- 2176US7981903B22-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancerGLAXOSMITHKLINE LLC·Filed 2008·Granted Jul 19, 2011·4 cites·17 claims
- 2275US9127088B2Glucagon superfamily peptides exhibiting nuclear hormone receptor activityDIMARCHI RICHARD D·Filed 2011·Granted Sep 8, 2015·2 cites·23 claims
- 2375US7226741B2Multimerization of HIV-1 Vif protein as a therapeutic targetUNIV JEFFERSON·Filed 2003·Granted Jun 5, 2007·2 cites·13 claims
- 2475US2025214977A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2574US12077530B2Chemical compoundsASTRAZENECA AB·Filed 2021·Granted Sep 3, 2024·0 cites·11 claims
- 2673US8338573B2Crystal structure of CD147 extracellular region and use thereofCHEN ZHINAN·Filed 2007·Granted Dec 25, 2012·2 cites·4 claims
- 2771US10590132B2Selective estrogen receptor down-regulatorsASTRAZENECA AB·Filed 2019·Granted Mar 17, 2020·0 cites·12 claims
- 2870US10961241B2Chemical compoundsASTRAZENECA AB·Filed 2020·Granted Mar 30, 2021·0 cites·9 claims
- 2969US10221173B2Chemical compoundsASTRAZENECA AB·Filed 2018·Granted Mar 5, 2019·0 cites·24 claims
- 3069US10196665B2Cell culture medium and methods for enhancing recombinant antibody puritySUNSHINE LAKE PHARMA CO LTD·Filed 2017·Granted Feb 5, 2019·2 cites·13 claims
- 3167US2023135894A1Mk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3266US11046689B2Selective estrogen receptor down-regulatorsASTRAZENECA AB·Filed 2020·Granted Jun 29, 2021·0 cites·5 claims
- 3366US10590130B2Chemical compoundsASTRAZENECA AB·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 3466US2025375460A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3564US2025019388A1Stat3 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3663US2025214969A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3762US2025205342A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3860US12194004B2Nano-delivery carrier for targeted tumor administration and application thereofGUIZHOU PROVINCIAL PEOPLES HOSPITAL·Filed 2024·Granted Jan 14, 2025·0 cites·5 claims
- 3960US2025179075A1Mk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4058US2003219414A1Recombinant adeno-associated virus virions for the treatment of lysosomal disordersFiled 2003·Application pending·0 cites
- 4158US2025213586A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4258US2025197387A1Bcl-xl degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4357US2024293423A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4456US2006104954A1Recombinant adeno-associated virus virions for the treatment of lysosomal disordersCHILDRENS HOSP & RES CT OAK·Filed 2006·Application pending·0 cites
- 4555US10149839B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Dec 11, 2018·0 cites·8 claims
- 4655US2024016942A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4755US2004146522A1Multimerization of HIV-1 Vif protein as a therapeutic targetFiled 2003·Application pending·0 cites
- 4853US10125135B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Nov 13, 2018·0 cites·12 claims
- 4951US8859491B2Glucagon superfamily peptides exhibiting glucocorticoid receptor activityUNIV INDIANA RES & TECH CORP·Filed 2012·Granted Oct 14, 2014·0 cites·28 claims
- 5050US12085566B2Inert carrier Salmonella and potential use thereofUNIV YANGZHOU·Filed 2020·Granted Sep 10, 2024·0 cites·2 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bin Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →